Sequencing and COVID-19
A growing number of methods and products are being developed and shared by the scientific community around the world for use in COVID-19-related work. A selection of preprints and protocols is shown below. These include methods for sequencing of SARS-CoV-2 and metatranscriptome analysis of COVID-19 samples, with applications in areas including epidemiology, metagenomic analysis and diagnostics.
Please note that preprints, protocols, and early access publications have not completed a peer-review process.
Information on primer overlaps with Omicron and Delta variants can be found here.
Nanopore sequencing
NEBNext® ARTIC SARS-CoV-2 Companion Kit (Oxford Nanopore Technologies®) |
|
nCoV-2019 sequencing protocol v3 (LoCost) This new version of the ARTIC protocol updates the RT and ligation reagents used, reduces reaction volumes and enables increased multiplexing. This updated method is also described in a bioRxiv preprint Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore.
|
|
nCoV-2019 sequencing protocol v2 ARTIC amplicon sequencing protocol for MinION for nCoV-2019, incorporating one-pot native barcoding.
|
|
PCR tiling of SARS-CoV-2 virus with Native Barcoding Expansion 96 (EXP-NBD196) This method, based on the ARTIC Network protocol by Josh Quick (see above), generates 400bp tiled amplicons and includes updated cDNA synthesis and ligation steps. The method enables additional barcoding and is compatible with Oxford Nanopore Technologies sequencing on MinION or GridION.
|
|
PCR tiling of SARS-CoV-2 virus This updated version of this protocol, based on the ARTIC Network protocol by Josh Quick, generates 400bp tiled amplicons, followed by Oxford Nanopore Technologies sequencing. This version includes updated cDNA synthesis and ligation steps.
|
|
nCoV-2019 environmental sample sequencing protocol
|
|
LamPORE: rapid, accurate and highly scalable molecular screening for SARS-CoV-2 infection, based on nanopore sequencing James, P. et al. Oxford Nanopore Technologies This fast, scalable method has testing and screening applications, employing LAMP-based amplification followed by library construction and nanopore sequencing.
|
|
Long reads nanopore sequencing to recover SARS-CoV-2 whole genome v.3 This protocol builds long (~2kb) amplicon libraries of SARS-CoV-2 genomes, suitable for nanopore sequencing.
|
|
Rapid detection of SARS-CoV-2 and other respiratory viruses by using LAMP method with Nanopore Flongle workflow This method combines LAMP with the Oxford Nanopore Flongle workflow, to detect SARS-CoV-2 and other respiratory viruses.
|
Illumina sequencing
NEBNext® ARTIC SARS-CoV-2 FS Library Prep Kit (Illumina®) |
|
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
|
|
Local emergence and decline of a SARS-CoV-2 variant with mutations L452R and N501Y in the spike protein Mallm, J. P. et al. DKFZ, Heidelberg University, NCT, HI-STEM, DKTK The authors used whole genome SARS-CoV-2 sequencing, using the NEBNext ARTIC SARS-CoV-2 FS Library Prep Kit (Illumina) to surveil SARS-CoV-2 positive samples.
|
|
COVID-19 ARTIC v3 Illumina library construction and sequencing protocol V.5 Using the ARTIC SARS-CoV-2 primers, this protocol generates libraries of 400bp tiled amplicons, followed by sample pooling and sequencing on the Illumina NovaSeq.
|
|
COVID-19 ARTIC v3 Illumina library construction and sequencing protocol - high throughput 384 format V.2 For higher density of sample processing, this adaptation of the COVID-19 ARTIC v3 protocol is compatible with 384 samples.
|
|
COVID-19 ARTIC v3 Illumina library construction and sequencing protocol - short amplicons (275bp) This protocol describes production of 275nt amplicons, followed by library preparation and sample pooling. Any Illumina instrument with a 300 cycle (or greater) kit can then be used for sequencing.
|
|
COVID-19 ARTIC v3 Illumina library construction and sequencing protocol - tailed method This adaptation of the COVID-19 ARTIC v3 protocol makes libraries directly from the 400bp tiled amplicons, using a second PCR step and without conventional library construction.
|
|
UCSF CAT COVID-19 Tailed 275bp v3 ARTIC protocol v1 V.1 Martinez, D. et al. UCSF Center for Advanced Technology, Biochemistry and Biophysics This tailed amplicon protocol generates 275bp tiled amplicons, compatible with 2 x 150 paired end sequencing.
|
|
SARS-CoV-2 Enrichment Sequencing by Spiked Primer MSSPE method V.4 Incorporating a spiked primer enrichment step, this protocol generates libraries suitable for sequencing on the Illumna iSeq100.
|
|
Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions Butler, D.J. et al. Weill Cornell Medicine, New York Genome Center, Baylor College of Medicine, University Hospital Tuebingen, Columbia University, University of California, San Francisco, DNAnexus, Inc., Root Deep Insight, NanoString Technologies, Biotia, Inc., SUNY Downstate Health Sciences University, Rutgers Cancer Institute, Robert Wood Johnson Medical School, National Center for Biotechnology Information, National Institutes of Health, Hangzhou Cancer Hospital, HudsonAlpha Discovery Institute This publication includes a large-scale shotgun metatranscriptomic profiling platform for nasopharyngeal swabs, with Illumina sequencing, and use of Colorimetric LAMP to detect SARS-CoV-2 infection.
|
|
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States This publication includes RNA library preparation from passaged virus sequencing on the Illumina MiniSeq.
|
|
Early Spread of SARS-Cov-2 in the Icelandic Population Using the ARTIC tiled primer method, the authors generated libraries which were pooled and sequenced on the Illumina MiSeq.
|
|
Introductions and early spread of SARS-CoV-2 in France The authors sequenced samples collected in France between January and March, 2020, including samples with low viral loads (<10,000 viral copies/ul of extracted RNA).
|
|
LAMP-Seq: Population-Scale COVID-19 Diagnostics Using Combinatorial Barcoding This method proposes use of barcoded RT-LAMP followed by large-scale pooling, PCR amplification with additional barcoding and deep sequencing on the Illumina platform.
|
Product Citation Tool
View citations that utilize NEB products using the Product Citation Tool. Refine your search by updating search field and then selecting a filter type. For your convenience, COVID-19 has been selected as a filter on this page.
"GMP-grade" is a branding term NEB uses to describe reagents manufactured or finished at NEB’s Rowley facility. The Rowley facility was designed to manufacture reagents under more
rigorous infrastructure and process controls to achieve more stringent product specifications and customer requirements. Reagents manufactured at NEB’s Rowley facility are
manufactured in compliance with ISO 9001 and ISO 13485 quality management system standards. However, at this time, NEB does not manufacture or sell products known as
Active Pharmaceutical Ingredients (APIs), nor does NEB manufacture its products in compliance with all of the Current Good Manufacturing Practice regulations.
Products and content are covered by one or more patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc (NEB). The use of trademark symbols does not necessarily indicate that the name is trademarked in the country where it is being read; it indicates where the content was originally developed. The use of this product may require the buyer to obtain additional third-party intellectual property rights for certain applications. For more information, please email busdev@neb.com.
Welcome to the COVID-19 researcher spotlight
Hear from scientists around the world as they discuss publications related to COVID-19, new protocols and techniques for detection and characterization, as well as how the scientific community is coming together to address this pandemic...all in 19 minutes or less!
Listen as we interview Dr. Peter Hotez, a physician-scientist and recognized expert in neglected tropical diseases and vaccine development. We discuss Dr. Hotez’s new book, Preventing the Next Pandemic: Vaccine Diplomacy in a Time of Anti-science, and his thoughts on the current COVID-19 pandemic, vaccine development and manufacturing, as well as democratizing vaccine distribution.
Listen nowPast researcher spotlight topics
Catch up on previous discussions related to COVID-19 research in these podcasts and videos:
- COVID-19 Researcher Spotlight: Interview with Bas Oude Munnink
- COVID-19 Researcher Spotlight: Interview with Bijoyita Roy
- COVID-19 Researcher Spotlight: Interview with Chan Zuckerberg Biohub Scientists
- COVID-19 Researcher Spotlight: Interview with Joshua Quick
- COVID-19 Researcher Spotlight: Interview with Chris Mason
- Lessons from Lab and Life Podcast – Interview with Naama Geva-Zatorsky: Applying LAMP to unpurified swab and saliva samples
- COVID-19 Researcher Spotlight: Interview with Nathan Tanner
- COVID-19 Researcher Spotlight: Interview with Greg Patton
- Lessons from Lab and Life Podcast – Interview with the founders of STOPCovid: Feng Zhang, Omar Abudayyeh and Jonathan Gootenberg
- Lessons from Lab and Life Podcast – Interview with Brian Rabe: Applying RT-LAMP to develop a fast SARS-CoV-2 diagnostic assay
- NEB TV Ep. 23 – Colorimetric LAMP in point-of-care diagnostics
Doing COVID-19 related research?
Let us know what you are working on, so we can keep you informed on new COVID-19 related products and publications available from NEB.
Stay InformedInterested in larger quantities?
Requests to obtain any of these products in
larger quantities in connection with the COVID-19
crisis should be forwarded to bulks@neb.com.
For more general inquiries or questions, please
feel free to contact us at info@neb.com.